Vizamyl

Chemical Nameflutemetamol F 18 injection
Dosage FormInjection (intravenous; 150 MBq/mL (4.05 mCi/mL)
Drug ClassRadioactive diagnostic agents
SystemNervous
CompanyGE Healthcare
Approval Year2013

Indication

  • For Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) or other causes of cognitive decline.
Last updated on 4/29/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Vizamyl (flutemetamol F 18 injection) Prescribing Information2013GE Healthcare, Medi-Physics, Inc., Arlington Heights, IL